Pharmaceutical Executive: What impact will TrumpRx and other DTC programs have on drug availability? Jesse Mendelsohn: To be ...
Peptilogics Founder and CEO, Jonathan Steckbeck, explained that PLG0206’s membrane-active mechanism enables it to destroy both active and dormant biofilm bacteria overcoming a key limitation of ...
Image Credit: Adobe Stock Images/zaie. The Supply Chain Biodiversity Footprinting (SCBF), a science-based, spatially explicit method rooted in Life Cycle Impact Assessment (LCIA), to quantify, ...
An analysis of pricing data for 12 high-revenue drugs from Medicare Part B and Part D compares US wholesale acquisition costs with the lowest prices in reference countries under the most-favored ...
Novo Nordisk will hold an Extraordinary General Meeting to elect new board members due to a disagreement with the Foundation ...
Sanofi's Tzield gains FDA's expedited review, promising rapid access to innovative treatment for type 1 diabetes and ...
The MFN pricing approach, while politically attractive, raises complex questions about how to fairly and sustainably price ...
The adoption of artificial intelligence (AI) has accelerated, yet its impact on R&D productivity remains underwhelming.
Galapagos announced plans to scale back on its cell therapy business, while the company pursues new transformational business ...
In light of the recent Congressional Budget Office report highlighting the impact of lower National Institutes of Health ...
In today’s Pharmaceutical Executive Daily, we cover the FDA’s creation of a new National Priority Voucher Program, the market ...
Frontier Scientific Solutions, a contract service organization (CSO), and Air Transport Services Group, a provider of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback